A cheeky website about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. If you have a tip or want to discuss a story please feel free to email Betaville at ben@betaville.co.uk. Betaville can also be reached at Whats App, Signal or Telegram. Betaville's Twitter handle is @bharringtonw11 and you can message me via Twitter with stories.

Trading on diarrhoea... - Part 2

Thursday, 11 June 2020, 1:41 pm

First Immuron; now Jiayin Group.

The US-listed Chinese digital marketplace is in focus after it leapt over 800pc during intraday trading yesterday, rising from $2.9 to an intrday high of $29.

The stock eventually closed at $5.8.

And today the company just announced its first quarter figures (the the link below):..

Read more...

Cash calls - who is next? - Part 12

Thursday, 11 June 2020, 11:25 am

The equity fundraisings (see Ocado) continue unabated, so Betaville is putting Greggs on the "cash calls - who is next?" list as scribblers at HSBC were suggesting the baker would likely come to the market and ask shareholders for fresh funds in the coming weeks.

So, below is the updated list:

1. International Consolidated Airlines Group

2. InterContinental Hotels Group

3. Mitchells & Butlers

4. Kingfisher

5. Provident Financial..

Read more...

Tags: Greggs
Betaville Intelligence

UNCOOKED ALERT: Clinigen said to ... - Part 2

Wednesday, 10 June 2020, 2:52 pm

Advent International is the mystery buyer stalking Clinigen but it's not clear whether it is still in "live" takeover talks with the Aim-listed medical supplies company.

Several people following the situation said Advent - which has carried out several investments in the healthcare and pharmaceutical industries - has been working Goldman Sachs and HSBC on a multi-million debt package for a possible takeover of Clinigen...

Read more...

Tags: Clinigen

Trading on diarrhoea...

Wednesday, 10 June 2020, 1:40 pm

It's not often a stock jumps a 1000pc in day. But yesterday Immuron, an Australian biopharmaceutical company that trades on Nasdaq, did exactly that on hopes it may develop a new treatment for diarrhoea.

Yes folks you read that correctly - diarrhoea...

Read more...

Tags: Immuron

Cash calls - who is next? - Part 11

Tuesday, 9 June 2020, 9:55 pm

Betaville is placing Rolls-Royce (no pun intended) on the ""cash calls - who is next?" list.

Now, readers might be asking why given the lockdowns are ending and stockmarkets are recovering.

Well, some very large and influential institutional investors suggested to little old Betaville an equity capital raising at Rolls-Royce is likely in the next few months...

Read more...

Betaville Intelligence

RARE ALERT: Seafox said to have lifted Gulf Marine Services stake to just over 29pc

Friday, 5 June 2020, 1:18 pm

Seafox International has been accumulating more stock in Gulf Marine Services, the Abu Dhabi-based oilfield services company that it tried to buy last month.

People following the situation said Seafox, which runs "jack-up" units for oil and gas explorers, now owns around 29pc of Gulf Marine after disclosing earlier this week that it had lifted its shareholding to 26.41pc.

The move comes after Seafox offered 10p a share for Gulf Marine Services...

Read more...

Betaville Intelligence

UNCOOKED ALERT: Urban Exposure said to ... - Part 3

Friday, 5 June 2020, 9:05 am

Speculation is mounting a mystery suitor is set to launch a tender offer for some or all of Urban Exposure, the Aim-listed property finance company.

People following the situation said an unknown acquirer is weighing launching a tender offer at between 55p and 65p a share.

Urban Exposure has been carrying out a strategic review after receiving several proposals for its loan book, including one from the Wellesley Group, an investment company run by the Earl of Cowley...

Read more...

Betaville Intelligence

UNCOOKED ALERT: Clinigen said to ...

Thursday, 4 June 2020, 3:57 pm

Clinigen, an Aim-listed medical supplies company, has come under the spotlight amid takeover talk.

People following the situation said a potential acquirer is eyeing the company, which supplies drugs for clinical trials and also distributes unlicensed pharmaceuticals to pharmacists.

One person following the situation suggested purchaser could be a private equity firm...

Read more...

Tags: Clinigen

Tiziana Life Sciences back under the spotlight... - Part 10

Thursday, 4 June 2020, 5:52 am

It's that time of the week when Betaville writes about Tiziana Life Sciences, the Aim-listed biopharmceutical developer.

Well, readers might recall that last Friday I suggested there are all sorts of things brewing at Tiziana Life Sciences.

And I understand some fresh data could emerge in the next week that could be transformational for the business, making Tiziana Life Sciences of interest to the pharmaceutical giants...

Read more...

Betaville Intelligence

RARE ALERT: Avacta Group said to be working on a multi-million pound equity fundraising

Thursday, 4 June 2020, 5:48 am

Avacta Group, the Aim-listed developer of a saliva test for Coronavirus, is said to be looking to tap investors for up to £30 million.

People following the situation said that Avacta is working with brokers from finnCap an equity capital raising via an accelerated bookbuild.

It's thought Avacta is considering issuing new shares at between 110p and 120p a share with a view to raising as much as £30 million...

Read more...

Punters placing bets LVMH's $16 billion takeover of Tiffany could be in trouble, according to Gasparino - Part 5

Wednesday, 3 June 2020, 8:12 am

Tiffany's shares slumped almost 10pc overnight amid a talk LVMH is getting cold feet again about the $16 billion takeover.

This time, though, it's not Gasparino but Women's Wear Daily stoking concerns with a report claiming LVMH's board members are to hold/held a meeting to discuss whether the company should back out of the deal. Below is a link to the WWD scoop:..

Read more...

Canary Wharf owner pounces on British Land with 7pc shareholding - Part 2

Saturday, 30 May 2020, 8:35 am

One of Betaville's favourite City writers offered an interesting view on Brookfield's surprise 7pc stakebuild in FTSE 100-listed British Land: "Acerbic" Alistair Osborne, a former Telegraph colleague and chief business commentator at The Times.

So, I have pasted a link to Alistair's piece below should you have a few spare minutes to catch up on the news this weekend:..

Read more...

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].